You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Addison's disease

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Study to Assess Choroideremia (CHM) Health Outcomes

Completed
  • Choroideremia
  • No Intervention
  • Los Angeles, California
  • +7 more
Oct 13, 2021

Psoriasis Trial in Sohag (serum samples and punch skin biopsies)

Recruiting
  • Psoriasis
  • serum samples and punch skin biopsies
  • Sohag, Egypt
    Faculty of Medicine Sohag University
Mar 27, 2022

Diabetic Kidney Disease Trial in Worldwide (Fulacimstat (BAY1142524), Placebo)

Completed
  • Diabetic Kidney Disease
  • Fulacimstat (BAY1142524)
  • Placebo
  • Dimitrovgrad, Bulgaria
  • +26 more
Feb 16, 2022

Primary Progressive Nonfluent Aphasia Trial in Vancouver (Active iTBS, Sham iTBS)

Terminated
  • Primary Progressive Nonfluent Aphasia
  • Active iTBS
  • Sham iTBS
  • Vancouver, British Columbia, Canada
    Non-Invasive Neurostimulation Therapies lab, University of Briti
Feb 14, 2022

COVID-19 Pandemic Trial in Siirt (Animation-Supported Education)

Completed
  • COVID-19 Pandemic
  • Animation-Supported Education
  • Siirt, Turkey
    Siirt University
Nov 29, 2022

Hemoperfusion Efferon ?T for the Treatment of Acute Pancreatitis

Recruiting
  • Acute Pancreatitis With Uninfected Necrosis, Unspecified
  • Efferon CT
  • Moscow, Russian Federation
    N.V. Sklifosovsky Moscow Research Institute of Emergency
Jan 25, 2023

Colorectal Cancer Trial in Shanghai, Hangzhou, Ningbo (Capecitabine tablets, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
  • +3 more
Jan 16, 2023

Urinary Uromodulin and Corresponding Urinary Exosomal UMOD mRNA

Completed
  • Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression
  • ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
  • Tanta, Al Gharbia, Egypt
    Tanta university hospital, faculty of science, tanta university
Jan 24, 2023

Disease Activity and Adverse Events of RINVOQ in Adult

Recruiting
  • Ankylosing Spondylitis
    • Kasugashi, Aichi, Japan
    • +22 more
    Jan 24, 2023

    STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Trial in Aurora, New York (Glycerol Phenylbutyrate 1100

    Active, not recruiting
    • STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
    • Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
    • Aurora, Colorado
    • +1 more
    Jan 24, 2023

    PROMISE: Percutaneous peRipheral cannulatiOn for

    Recruiting
    • Heart Valve Diseases
    • +3 more
      • Hamburg, Germany
        University Heart and Vascular Center Hamburg, University Medical
      Jul 17, 2023

      Covid19 Trial in Stanford (Angiotensin-(1-7), Placebo)

      Withdrawn
      • Covid19
      • Stanford, California
        Stanford University
      Feb 15, 2022

      Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4, Diabetes, Type 2 Trial in Sweden (Sulforaphane, administered as

      Completed
      • Chronic Kidney Disease Stage 3B
      • +2 more
      • Sulforaphane, administered as Broccoli sprout extract
      • Göteborg, Sweden
      • +7 more
      Jan 16, 2023

      Lyme Disease Diagnostic Assay - Collection of Whole Blood

      Enrolling by invitation
      • Lyme Disease
      • Healthy
      • Lyme diagnostic assay
      • Stillwater, Minnesota
        DiaSorin Inc.
      Sep 10, 2021

      Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

      Completed
      • Ulcerative Colitis
      • Milano, Italy
        Mariangela Allocca
      Feb 13, 2023

      Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

      Recruiting
      • Head and Neck Squamous Cell Cancer
      • Toripalimab Injection
      • Cetuximab Solution for infusion
      • Shanghai, China
        Shanghai East Hospital
      Dec 15, 2022

      Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B Trial in Buffalo

      Recruiting
      • Non-Alcoholic Steatohepatitis(NASH)
      • +7 more
        • Buffalo, New York
          University at Buffalo, Buffalo General Medical Center
        Apr 15, 2022

        Deep Phenotyping of Bone Disease in Type 2 Diabetes and

        Not yet recruiting
        • Type 2 Diabetes
        • +4 more
        • Dual Energy X-ray Absorbtiometry scan
        • +13 more
        • (no location specified)
        Dec 9, 2022

        Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver

        Recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Sigmoidoscopy
        • Orlando, Florida
          AdventHealth Translational Research Institute
        Apr 12, 2022

        Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan

        Active, not recruiting
        • HIV/AIDS
        • +2 more
          • Indianapolis, Indiana
          • +1 more
          Apr 12, 2022

          Alzheimer Trial in New Haven ([18F]MNI-1020)

          Completed
          • Alzheimer Disease
          • New Haven, Connecticut
            Invicro
          Aug 17, 2022

          Patient Forward Access to Clinical and Technological Research:

          Completed
          • Eczema/Atopic Dermatitis
          • Cancer
            • Boston, Massachusetts
              Boston Children's Hopsital
            May 6, 2022

            Breast Cancer Trial in Toronto (SBRT)

            Recruiting
            • Breast Cancer
            • SBRT
            • Toronto, Ontario, Canada
              Sunnybrook Odette Cancer Centre
            May 5, 2022

            Neuroendocrine Tumor, Gastroenteropancreatic Trial in Milano (Surgery)

            Active, not recruiting
            • Neuroendocrine Tumor
            • Gastroenteropancreatic
            • Surgery
            • Milano, Italy
              San Raffaele Hospital IRCCS
            May 5, 2022

            Safety of Exposure to Natalizumab During Pregnancy

            Recruiting
            • Multiple Sclerosis
            • Questionnaire
            • Besançon, France
            • +26 more
            Jun 27, 2022